Status:

WITHDRAWN

Emergency Ventilator Splitting Between Two or More Patients (COVID-19)

Lead Sponsor:

Stanford University

Conditions:

COVID-19

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The purpose of this study is to develop a safe, easily scalable, and simple method to split a single ventilator for use amongst two or more patients, thus serving as a capacity bridge to save patient ...

Eligibility Criteria

Inclusion

  • Phase I
  • Undergoing routine thoracic surgery which will include the use of a dual lumen endotracheal tube at Stanford.
  • Phase II
  • Able to give consent
  • On venovenous extracorporeal membrane oxygenation for reason other than COVID-19
  • Phase III
  • Able to give consent
  • Infected with COVID-19 and will likely require mechanical ventilation.

Exclusion

  • Phase I
  • Significant cardiac comorbidities
  • Liver disease
  • Phase II
  • Significant cardiac comorbidities
  • Pre or Post-transplant patient
  • Infection with COVID-19
  • Phase III
  • Co-infection with disease aside from COVID-19
  • Severely ill requiring high ventilator requirements and not stable for ventilator splitting

Key Trial Info

Start Date :

June 1 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 1 2021

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT04381013

Start Date

June 1 2021

End Date

July 1 2021

Last Update

June 25 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Stanford University

Stanford, California, United States, 94304

Emergency Ventilator Splitting Between Two or More Patients (COVID-19) | DecenTrialz